The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Predictive serum biomarkers in metastatic colorectal cancer (mCRC) patients treated in the BECOX trial with oxaliplatin-capecitabine (CAPOX) plus bevacizumab (BVZ) (GEMCAD 09-01).
 
Estela Pineda
Honoraria - Roche Pharma AG
Research Funding - Roche Pharma AG (Inst)
Travel, Accommodations, Expenses - Roche Pharma AG
 
Antonieta Salud
No Relationships to Disclose
 
Elena Vila-Navarro
No Relationships to Disclose
 
Maria Jose Safont
No Relationships to Disclose
 
Carlos Garcia-Giron
No Relationships to Disclose
 
Jorge Aparicio
No Relationships to Disclose
 
Ruth Vera
No Relationships to Disclose
 
M. Pilar Escudero
No Relationships to Disclose
 
Enrique Casado
Stock and Other Ownership Interests - PharmaMar
Consulting or Advisory Role - Amgen; Roche Pharma AG
Patents, Royalties, Other Intellectual Property - Roche
 
Carlos Bosch
No Relationships to Disclose
 
Uriel Bohn
No Relationships to Disclose
 
Ramon Maria Perez Carrion
No Relationships to Disclose
 
Alberto Carmona Bayonas
No Relationships to Disclose
 
Juan Ramón Ayuso
No Relationships to Disclose
 
Tomas Ripolles
No Relationships to Disclose
 
Rosa Bouzas
No Relationships to Disclose
 
Meritxell Gironella
No Relationships to Disclose
 
Xabier Garcia-Albeniz
No Relationships to Disclose
 
Jaime Feliu
No Relationships to Disclose
 
Juan Maurel
No Relationships to Disclose